Federated Hermes’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$400M Sell
1,136,518
-662,922
-37% -$236M 0.65% 37
2025
Q4
$589M Sell
1,799,440
-288,114
-14% -$91.4M 0.98% 12
2025
Q3
$589M Sell
2,087,554
-84,270
-4% -$24.4M 1.04% 10
2025
Q2
$606M Buy
2,171,824
+134,655
+7% +$38.1M 1.14% 8
2025
Q1
$635M Buy
2,037,169
+665,555
+49% +$197M 1.37% 7
2024
Q4
$357M Buy
1,371,614
+389,099
+40% +$115M 0.78% 18
2024
Q3
$317M Sell
982,515
-334,923
-25% -$110M 0.7% 27
2024
Q2
$412M Sell
1,317,438
-154,489
-10% -$45.4M 0.98% 13
2024
Q1
$418M Sell
1,471,927
-266,768
-15% -$78.1M 0.96% 11
2023
Q4
$501M Sell
1,738,695
-760,949
-30% -$207M 1.24% 5
2023
Q3
$672M Buy
2,499,644
+26,045
+1% +$6.5M 1.79% 3
2023
Q2
$549M Buy
2,473,599
+767,581
+45% +$178M 1.36% 8
2023
Q1
$412M Buy
1,706,018
+366,044
+27% +$89.9M 1.04% 14
2022
Q4
$352M Sell
1,339,974
-788,748
-37% -$211M 0.97% 16
2022
Q3
$480M Buy
2,128,722
+297,558
+16% +$72.1M 1.41% 5
2022
Q2
$446M Buy
1,831,164
+346,190
+23% +$84.8M 1.21% 6
2022
Q1
$359M Sell
1,484,974
-58,433
-4% -$13.4M 0.81% 14
2021
Q4
$347M Buy
1,543,407
+243,451
+19% +$51.4M 0.65% 18
2021
Q3
$276M Buy
1,299,956
+381,161
+41% +$87.7M 0.53% 30
2021
Q2
$224M Buy
918,795
+1,798
+0.2% +$442K 0.42% 45
2021
Q1
$228M Sell
916,997
-19,819
-2% -$4.73M 0.44% 39
2020
Q4
$215M Sell
936,816
-15,572
-2% -$3.59M 0.44% 41
2020
Q3
$242M Sell
952,388
-17,147
-2% -$4.25M 0.57% 31
2020
Q2
$229M Sell
969,535
-46,524
-5% -$10.6M 0.57% 34
2020
Q1
$206M Sell
1,016,059
-124,054
-11% -$27.1M 0.61% 29
2019
Q4
$275M Buy
1,140,113
+819,628
+256% +$181M 0.61% 27
2019
Q3
$62M Sell
320,485
-2,047
-0.6% -$393K 0.15% 156
2019
Q2
$59.4M Buy
322,532
+1,799
+0.6% +$322K 0.14% 160
2019
Q1
$60.9M Sell
320,733
-31,848
-9% -$6.08M 0.15% 147
2018
Q4
$68.6M Sell
352,581
-221
-0.1% -$43.1K 0.19% 114
2018
Q3
$73.1M Buy
352,802
+263,736
+296% +$52M 0.17% 131
2018
Q2
$16.4M Sell
89,066
-118,487
-57% -$21M 0.05% 308
2018
Q1
$35.4M Sell
207,553
-4,027
-2% -$739K 0.1% 168
2017
Q4
$36.8M Buy
211,580
+13,648
+7% +$2.42M 0.1% 160
2017
Q3
$36.9M Sell
197,932
-1,111
-0.6% -$197K 0.11% 163
2017
Q2
$34.3M Sell
199,043
-131,778
-40% -$21.4M 0.1% 173
2017
Q1
$54.3M Sell
330,821
-56,933
-15% -$9.46M 0.15% 126
2016
Q4
$56.7M Sell
387,754
-26,730
-6% -$4.02M 0.17% 117
2016
Q3
$69.1M Sell
414,484
-56,226
-12% -$9.51M 0.2% 92
2016
Q2
$71.6M Buy
470,710
+51,078
+12% +$7.94M 0.21% 86
2016
Q1
$62.9M Buy
419,632
+49,052
+13% +$7.29M 0.2% 91
2015
Q4
$60.2M Sell
370,580
-28,938
-7% -$4.55M 0.19% 106
2015
Q3
$55.3M Sell
399,518
-1,638
-0.4% -$258K 0.18% 115
2015
Q2
$61.6M Buy
401,156
+102,447
+34% +$16.4M 0.18% 111
2015
Q1
$47.7M Buy
298,709
+180,233
+152% +$28.4M 0.15% 143
2014
Q4
$18.9M Buy
118,476
+47,759
+68% +$7.44M 0.06% 301
2014
Q3
$9.93M Buy
70,717
+1,835
+3% +$240K 0.03% 444
2014
Q2
$8.15M Sell
68,882
-41,780
-38% -$4.84M 0.03% 506
2014
Q1
$13.6M Sell
110,662
-167,253
-60% -$20.3M 0.05% 381
2013
Q4
$31.7M Buy
277,915
+23,831
+9% +$2.71M 0.11% 176
2013
Q3
$28.4M Sell
254,084
-128,505
-34% -$13.9M 0.11% 167
2013
Q2
$37.7M Buy
+382,589
New +$39.7M 0.15% 132

Other funds holding AMGN

Federated Hermes's AMGN Position: Q1 2026 in Review

Federated Hermes reduced its Amgen (AMGN) stake by 37% in Q1 2026, selling an estimated $236M and leaving 1,136,518 shares worth $400M. The position accounts for 0.65% of the portfolio, ranked #37.

Federated Hermes first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $672M in Q3 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Federated Hermes held 1,136,518 shares of Amgen worth $400M as of Q1 2026.
  • Federated Hermes sold 662,922 Amgen shares in Q1 2026, an estimated $236M.
  • Amgen made up 0.65% of Federated Hermes's portfolio in Q1 2026, its #37 holding.
  • Federated Hermes first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Amgen position peaked at $672M in Q3 2023.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.